Release Date: 04/08/16 11:44 Summary: Appendix 4E and Annual Report 2016-LEP.AX Price Sensitive: Yes Download Document 4.8MB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status